Profil
Amir Dagan is associated with Enopace Biomedical Ltd.
as the Chief Executive Officer since its founding in 2008.
Postes actifs de Amir Dagan
| Sociétés | Poste | Début |
|---|---|---|
Enopace Biomedical Ltd.
 Enopace Biomedical Ltd. Medical SpecialtiesHealth Technology Enopace Biomedical Ltd. develops medical devices to treat heart failure patients. The firm's technology consists of a minimally invasive, implantable neurostimulation device that increases cardiac efficiency by reducing left ventricular workload and improves the systolic/diastolic ratio. The company was by Yossi Gross and Amir Dagan in 2008 and is headquartered in Caesarea, Israel. | Directeur Général | 16/06/2009 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Enopace Biomedical Ltd.
Enopace Biomedical Ltd. Medical SpecialtiesHealth Technology Enopace Biomedical Ltd. develops medical devices to treat heart failure patients. The firm's technology consists of a minimally invasive, implantable neurostimulation device that increases cardiac efficiency by reducing left ventricular workload and improves the systolic/diastolic ratio. The company was by Yossi Gross and Amir Dagan in 2008 and is headquartered in Caesarea, Israel. | Health Technology |
